CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
Jonghwa Ahn, Meihua Jin, Eyun Song, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Ji Min Han, Won Gu Kim
Endocrinol Metab. 2020;35(4):830-837.   Published online November 18, 2020
DOI: https://doi.org/10.3803/EnM.2020.747

Excel Download

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
Endocrinology and Metabolism. 2020;35(4):830-837   Crossref logo
Link1 Link2 Link3

Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma
Head & Neck. 2010;NA-NA   Crossref logo
Link1 Link2

Response to Tulchinsky and Avram re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine”
Thyroid. 2017;27(4):592-592   Crossref logo
Link1 Link2

Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 milliCuries Radioiodine
Thyroid. 2016;26(7):951-958   Crossref logo
Link1 Link2

Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma
Mayo Clinic Proceedings. 2021;96(7):1727-1745   Crossref logo
Link1 Link2

Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation
Clinical Oncology. 2012;24(3):162-168   Crossref logo
Link1 Link2

How to Distinguish Between Radioiodine Accumulation in a Laryngocele from a Radioiodine-Concentrating Thyroid Remnant After Thyroidectomy for Papillary Carcinoma
Thyroid. 2004;14(10):867-868   Crossref logo
Link1

Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma
Head & Neck. 2010;NA-NA   Crossref logo
Link1 Link2

Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
European Journal of Surgical Oncology. 2017;43(9):1802-1803   Crossref logo
Link1 Link2

Serum Thyroglobulin Levels at the Time of 131I Remnant Ablation Just After Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients With Differentiated Thyroid Carcinoma
Yearbook of Surgery. 2006;2006:153-154   Crossref logo
Link1 Link2